{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"39.86","upperLimit":"132.0","value":"62.9"},{"groupId":"OG001","lowerLimit":"50.43","upperLimit":"126.4","value":"64.6"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"40"},{"groupId":"OG001","value":"39"}],"units":"Participants"}],"description":"OS was defined as the time from the date of randomization until the date of death due to any cause.","dispersionType":"95% Confidence Interval","groups":[{"description":"Participants received Eribulin Mesylate 1.0 mg/m\\^2 (Recommended Phase 2 dose), as an intravenous infusion on Days 1 and 8 in combination with Gemcitabine 1000 mg/m\\^2, as an intravenous infusion on Days 1 and 8 and Cisplatin 70 mg/m\\^2, as an intravenous infusion on Day 1 of each 21-day cycle until the occurrence of PD, unacceptable toxicity, withdrawal of consent, withdrawal by the investigator, lost to follow-up, death, or for a maximum of six cycles of gemcitabine plus cisplatin (18 weeks), whichever occurred first.","id":"OG000","title":"Phase 2: Eribulin Mesylate 1.0 mg/m^2 + Gemcitabine 1000 mg/m^2+ Cisplatin 70 mg/m^2"},{"description":"Participants received Gemcitabine 1000 mg/m\\^2, as an intravenous infusion on Days 1 and 8 and cisplatin 70 mg/m\\^2, as an intravenous infusion on Day 1 of each 21-day cycle until the occurrence of PD, unacceptable toxicity, withdrawal of consent, withdrawal by the investigator, lost to follow-up, death, or for a maximum of six cycles of gemcitabine plus cisplatin (18 weeks), whichever occurred first.","id":"OG001","title":"Phase 2: Gemcitabine 1000 mg/m^2+ Cisplatin 70 mg/m^2"}],"paramType":"MEDIAN","populationDescription":"MITT analysis set included all participants who were randomized and received at least one dose of study medication without major protocol eligibility violations.","reportingStatus":"POSTED","timeFrame":"From the date of randomization until the date of death (Up to approximately 6 years 3 months)","title":"Phase 2: Overall Survival (OS)","type":"SECONDARY","unitOfMeasure":"weeks"}